By Peter Loftus —Sara Leitch and Mike Barris contributed to this article.
The Wall Street Journal Europe
24 Jul 2007
Merck & Co. continued its turnaround, posting a 12% increase in second-quarter profit on strong sales of drugs for allergies and cholesterol, as well as vaccines. The improved sales of cholesterol drugs Vytorin and Zetia also helped Merck’s... read more...
posted by Bank Report at
5:58 PM
0 Comments:
Post a Comment
<< Home